Cardiac β-Adrenoceptor Desensitization Due to Increased β-Adrenoceptor Kinase Activity in Chronic Uremia

ABSTRACT. Patients with chronic renal failure develop an autonomic dysfunction with impaired baroreflex control and attenuated cardiovascular β-adrenoceptor response to noradrenaline. In rats that underwent 5/6-nephrectomy (SNX), cardiac β-adrenoceptor responsiveness was reduced as well. Therefore, the aim of this study was to further investigate the mechanism underlying cardiac β-adrenoceptor desensitization in SNX rats. For this purpose, right and left ventricular β-adrenoceptor density, activity of the G-protein–coupled receptor kinase, and activity and density of the neuronal noradrenaline transporter (uptake 1 ) were assessed in SNX rats. Seven weeks after SNX, rats had developed left heart hypertrophy. Plasma creatinine, urea, and noradrenaline levels were significantly increased; left and right ventricular noradrenaline content was significantly decreased when compared with sham-operated control rats. In these SNX rats, left, but not right, ventricular β-adrenoceptor density was significantly reduced, and membrane-associated G-protein–coupled receptor kinase activity was significantly increased compared with sham-operated rats. Although right and left ventricular activity of uptake 1 was unchanged, the neuronal noradrenaline transporter density was significantly reduced in both ventricles of SNX versus sham-operated rats. An increase in left ventricular G-protein–coupled receptor kinase activity, possibly triggered by enhanced cardiac noradrenaline release, might be responsible for the decrease in left ventricular β-adrenoceptor responsiveness in SNX rats.

[1]  K. Leineweber,et al.  Chamber‐specific alterations of noradrenaline uptake (uptake1) in right ventricles of monocrotaline‐treated rats , 2000, British journal of pharmacology.

[2]  A. Levin,et al.  Cardiovascular disease in chronic renal insufficiency. , 2000, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[3]  S. Dhein,et al.  Cardiac beta-adrenoceptors in chronic uremia: studies in humans and rats. , 2000, Journal of the American College of Cardiology.

[4]  E. Ritz,et al.  Effects of low dose sympathetic inhibition on glomerulosclerosis and albuminuria in subtotally nephrectomized rats. , 2000, Journal of the American Society of Nephrology : JASN.

[5]  N. Hatori,et al.  Myocardial morphology and cardiac function in rats with renal failure. , 2000, Japanese circulation journal.

[6]  V. Campese,et al.  Neurogenic factors and hypertension in renal disease. , 2000, Kidney international. Supplement.

[7]  J L Benovic,et al.  Regulation of G protein-coupled receptor kinases. , 2000, Trends in cardiovascular medicine.

[8]  M. Michel,et al.  Adrenergic and muscarinic receptors in the human heart. , 1999, Pharmacological reviews.

[9]  W. Koch,et al.  Therapeutic potential of G-protein coupled receptor kinases in the heart. , 1999, Expert opinion on investigational drugs.

[10]  J. Benovic,et al.  G‐Protein–coupled receptor kinase expression in hypertension , 1999, Clinical pharmacology and therapeutics.

[11]  D. Wheeler Ischaemic heart disease after renal transplantation: how to assess and minimize the risk. , 1999, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[12]  P. Blankestijn,et al.  Reduction of sympathetic hyperactivity by enalapril in patients with chronic renal failure. , 1999, The New England journal of medicine.

[13]  S. Ertürk Long-term evolution of cardiomyopathy in dialysis patients. , 1999, Kidney international.

[14]  R. Lefkowitz,et al.  β-Adrenergic Receptor Kinase-1 Levels in Catecholamine-Induced Myocardial Hypertrophy Regulation by β- but not α1-Adrenergic Stimulation , 1999 .

[15]  R. Willette,et al.  The myocardial beta-adrenergic system in spontaneously hypertensive heart failure (SHHF) rats. , 1999, Hypertension.

[16]  A. Levey Controlling the epidemic of cardiovascular disease in chronic renal disease: where do we start? , 1998, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[17]  R. Lefkowitz,et al.  Reciprocal in vivo regulation of myocardial G protein-coupled receptor kinase expression by beta-adrenergic receptor stimulation and blockade. , 1998, Circulation.

[18]  C. Wingo,et al.  Hyperkalemia: a potential silent killer. , 1998, Journal of the American Society of Nephrology : JASN.

[19]  W. Koch,et al.  Mechanism of β-Adrenergic Receptor Desensitization in Cardiac Hypertrophy Is Increased β-Adrenergic Receptor Kinase* , 1997, The Journal of Biological Chemistry.

[20]  J. Benovic,et al.  G-protein-coupled receptor kinase activity is increased in hypertension. , 1997, The Journal of clinical investigation.

[21]  V. Campese,et al.  Renal afferent impulses, the posterior hypothalamus, and hypertension in rats with chronic renal failure. , 1997, Kidney international.

[22]  M. Michel,et al.  Influence of adrenoceptor and muscarinic receptor blockade on the cardiovascular effects of exogenous noradrenaline and of endogenous noradrenaline released by infused tyramine , 1997, Naunyn-Schmiedeberg's Archives of Pharmacology.

[23]  GertRichardt,et al.  Upregulation of Cardiac Uptake1 Carrier in Ischemic and Nonischemic Rat Heart , 1996 .

[24]  G. Richardt,et al.  Upregulation of cardiac uptake 1 carrier in ischemic and nonischemic rat heart. , 1996, Circulation research.

[25]  P. Whelton,et al.  Blood pressure and end-stage renal disease in men. , 1996, The New England journal of medicine.

[26]  E. Ritz,et al.  New insights into mechanisms of blood pressure regulation in patients with uraemia. , 1996, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[27]  M. Caron,et al.  Phosphorylation and desensitization of the human beta 1-adrenergic receptor. Involvement of G protein-coupled receptor kinases and cAMP-dependent protein kinase. , 1995, The Journal of biological chemistry.

[28]  E. Ritz,et al.  Changes of vascular architecture independent of blood pressure in experimental uremia. , 1995, American journal of hypertension.

[29]  M. Sallese,et al.  Regulation of G protein-coupled receptor kinase subtypes in activated T lymphocytes. Selective increase of beta-adrenergic receptor kinase 1 and 2. , 1995, The Journal of clinical investigation.

[30]  M. Böhm,et al.  Evidence for reduction of norepinephrine uptake sites in the failing human heart. , 1995, Journal of the American College of Cardiology.

[31]  R. Bigazzi,et al.  Altered norepinephrine turnover in the brain of rats with chronic renal failure. , 1994, Journal of the American Society of Nephrology : JASN.

[32]  E. Ritz,et al.  The effect of enalapril on glomerular growth and glomerular lesions after subtotal nephrectomy in the rat: a stereological analysis , 1993, Journal of hypertension.

[33]  M. Böhm,et al.  Altered expression of beta-adrenergic receptor kinase and beta 1-adrenergic receptors in the failing human heart. , 1993, Circulation.

[34]  M. Lohse,et al.  Altered Expression of, ‐Adrenergic Receptor Kinase and 1‐Adrenergic Receptors in the Failing Human Heart , 1993 .

[35]  R. Converse,et al.  Sympathetic overactivity in patients with chronic renal failure. , 1992, The New England journal of medicine.

[36]  J. Port,et al.  Myocardial Catecholamine and Neuropeptide Y Depletion in Failing Ventricles of Patients With Idiopathic Dilated Cardiomyopathy: Correlation With β‐Adrenergic Receptor Downregulation , 1992, Circulation.

[37]  J. Benovic Purification and characterization of beta-adrenergic receptor kinase. , 1987, Methods in enzymology.

[38]  J. Cohn,et al.  Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. , 1984, The New England journal of medicine.

[39]  C. Benedict,et al.  Catecholamines in peripheral venous plasma in patients on chronic haemodialysis. , 1978, Clinical science and molecular medicine.

[40]  J. A. Thomas,et al.  Plasma norepinephrine in congestive heart failure. , 1978, The American journal of cardiology.

[41]  J. Zingraff,et al.  Congestive cardiomyopathy in uraemic patients on long term haemodialysis. , 1977, British medical journal.

[42]  M. M. Bradford A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.

[43]  P. Nemes,et al.  The use of Coomassie Brilliant Blue G250 perchloric acid solution for staining in electrophoresis and isoelectric focusing on polyacrylamide gels. , 1975, Analytical biochemistry.

[44]  U. K. Laemmli,et al.  Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.